Aerosolized red-tide toxins (brevetoxins) and asthma.

PubWeight™: 2.70‹?› | Rank: Top 1%

🔗 View Article (PMC 2683400)

Published in Chest on January 01, 2007

Authors

Lora E Fleming1, Barbara Kirkpatrick, Lorraine C Backer, Judy A Bean, Adam Wanner, Andrew Reich, Julia Zaias, Yung Sung Cheng, Richard Pierce, Jerome Naar, William M Abraham, Daniel G Baden

Author Affiliations

1: National Institute of Environmental Health Sciences Marine and Freshwater Biomedical Sciences Center, Rosenstiel School of Marine and Atmospheric Sciences, University of Miami, Miami, FL, USA. lfleming@med.miami.edu

Articles citing this

Skill assessment for an operational algal bloom forecast system. J Mar Syst (2009) 1.76

Neurotoxic shellfish poisoning. Mar Drugs (2008) 1.49

Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health. Proc Natl Acad Sci U S A (2013) 1.34

Reported respiratory symptom intensity in asthmatics during exposure to aerosolized Florida red tide toxins. J Asthma (2007) 1.34

Recreational exposure to low concentrations of microcystins during an algal bloom in a small lake. Mar Drugs (2008) 1.29

Impacts of climate variability and future climate change on harmful algal blooms and human health. Environ Health (2008) 1.21

Centers for Oceans and Human Health: a unified approach to the challenge of harmful algal blooms. Environ Health (2008) 1.19

Satellite remote sensing of harmful algal blooms: A new multi-algorithm method for detecting the Florida Red Tide (Karenia brevis). Harmful Algae (2010) 1.17

Review of Florida Red Tide and Human Health Effects. Harmful Algae (2011) 1.12

The costs of respiratory illnesses arising from Florida gulf coast Karenia brevis blooms. Environ Health Perspect (2009) 1.10

Long-term evaluation of three satellite ocean color algorithms for identifying harmful algal blooms (Karenia brevis) along the west coast of Florida: A matchup assessment. Remote Sens Environ (2011) 1.09

Linking the oceans to public health: current efforts and future directions. Environ Health (2008) 1.09

Florida red tide and human health: a pilot beach conditions reporting system to minimize human exposure. Sci Total Environ (2008) 1.02

Exposure and effect assessment of aerosolized red tide toxins (brevetoxins) and asthma. Environ Health Perspect (2009) 1.00

The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Toxins (Basel) (2010) 0.98

Marine harmful algal blooms, human health and wellbeing: challenges and opportunities in the 21st century. J Mar Biol Assoc U.K. (2015) 0.98

Environmental controls, oceanography and population dynamics of pathogens and harmful algal blooms: connecting sources to human exposure. Environ Health (2008) 0.96

Florida Red Tide Perception: Residents versus Tourists. Harmful Algae (2010) 0.95

Evaluation of harmful algal bloom outreach activities. Mar Drugs (2007) 0.92

Development of a competitive fluorescence-based synaptosome binding assay for brevetoxins. Harmful Algae (2012) 0.91

Public perceptions of Florida red tide risks. Risk Anal (2009) 0.89

Brevenal, a brevetoxin antagonist from Karenia brevis, binds to a previously unreported site on mammalian sodium channels. Harmful Algae (2013) 0.89

Inland Transport of Aerosolized Florida Red Tide Toxins. Harmful Algae (2010) 0.88

Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar Drugs (2008) 0.84

Detection of cyanotoxins, β-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis. Toxins (Basel) (2015) 0.84

Gastrointestinal Emergency Room Admissions and Florida Red Tide Blooms. Harmful Algae (2010) 0.83

Cyanobacteria and algae blooms: Review of health and environmental data from the Harmful Algal Bloom-Related Illness Surveillance System (HABISS) 2007-2011. Toxins (Basel) (2015) 0.82

Florida Red Tide Toxins (Brevetoxins) and Longitudinal Respiratory Effects in Asthmatics. Harmful Algae (2011) 0.79

A new cytotoxicity assay for brevetoxins using fluorescence microscopy. Mar Drugs (2014) 0.78

Beaches and HABs: Successful Expansion of the Florida Red Tide Reporting System for Protection of Public Health through Community Education and Outreach. Fla J Environ Health (2009) 0.78

Sentinel Animals in a One Health Approach to Harmful Cyanobacterial and Algal Blooms. Vet Sci (2016) 0.76

Prominent human health impacts from several marine microbes: history, ecology, and public health implications. Int J Microbiol (2010) 0.76

Changes in Work Habits of Lifeguards in Relation to Florida Red Tide. Harmful Algae (2010) 0.76

Selective algicidal action of peptides against harmful algal bloom species. PLoS One (2011) 0.76

Brevetoxin forms covalent DNA adducts in rat lung following intratracheal exposure. Environ Health Perspect (2008) 0.75

Airborne Microalgae: Insights, Opportunities, and Challenges. Appl Environ Microbiol (2016) 0.75

Megacities and large urban agglomerations in the coastal zone: interactions between atmosphere, land, and marine ecosystems. Ambio (2012) 0.75

Brevetoxin inhalation alters the pulmonary response to influenza A in the male F344 rat. J Toxicol Environ Health A (2011) 0.75

Marine Biotoxins: Occurrence, Toxicity, Regulatory Limits and Reference Methods. Front Microbiol (2016) 0.75

Characterization of Florida red tide aerosol and the temporal profile of aerosol concentration. Toxicon (2009) 0.75

Respiratory Problems Associated with Surfing in Coastal Waters. Ecohealth (2016) 0.75

Satellite Remote Sensing for Coastal Management: A Review of Successful Applications. Environ Manage (2017) 0.75

Articles cited by this

Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41

Literature Review of Florida Red Tide: Implications for Human Health Effects. Harmful Algae (2004) 5.00

A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid. Environ Health Perspect (2002) 4.14

Population disparities in asthma. Annu Rev Public Health (2005) 3.48

Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ Health Perspect (2005) 3.38

Occupational exposure to aerosolized brevetoxins during Florida red tide events: effects on a healthy worker population. Environ Health Perspect (2005) 3.27

Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays. Cell Mol Neurobiol (2004) 2.77

Brevetoxin concentrations in marine aerosol: human exposure levels during a Karenia brevis harmful algal bloom. Bull Environ Contam Toxicol (2003) 2.53

Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ Health Perspect (2005) 2.43

Airway responses to aerosolized brevetoxins in an animal model of asthma. Am J Respir Crit Care Med (2004) 2.40

Neurotoxic shellfish poisoning and brevetoxin metabolites: a case study from Florida. Toxicon (2000) 2.24

Environmental exposures to Florida red tides: Effects on emergency room respiratory diagnoses admissions. Harmful Algae (2006) 2.18

The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol (2005) 2.02

Red tide. Its public health implications. JFMA (1973) 1.89

Overview of aerosolized Florida red tide toxins: exposures and effects. Environ Health Perspect (2005) 1.78

Characterization of Red Tide Aerosol on the Texas Coast. Harmful Algae (2005) 1.75

Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention. Environ Health Perspect (2005) 1.73

Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days. Environ Health Perspect (2005) 1.70

Effects of toxin of red tide, Ptychodiscus brevis, on canine tracheal smooth muscle: a possible new asthma-triggering mechanism. J Allergy Clin Immunol (1982) 1.64

The epidemiology and genetics of asthma risk associated with air pollution. J Allergy Clin Immunol (2005) 1.60

Innovative techniques for harmful algal toxin analysis. Environ Toxicol Chem (2001) 1.34

The social and economic consequences of childhood asthma across the lifecourse: a systematic review. Child Care Health Dev (2004) 1.25

A strategy to reduce healthy worker effect in a cross-sectional study of asthma and metalworking fluids. Am J Ind Med (1997) 1.20

Short-term effects of low-level air pollution on respiratory health of adults suffering from moderate to severe asthma. Environ Res (2002) 1.16

Concentration and particle size of airborne toxic algae (brevetoxin) derived from ocean red tide events. Environ Sci Technol (2005) 1.13

Seasonal difference in the occurrence of exercise-induced bronchospasm in asthmatics: dependence on humidity. Respiration (2002) 1.13

Clinical and epidemiological features of neurotoxic shellfish poisoning in North Carolina. Am J Public Health (1991) 1.12

Spirometry and tests of bronchial hyperresponsiveness in population studies. Int J Tuberc Lung Dis (2000) 0.90

Articles by these authors

Literature Review of Florida Red Tide: Implications for Human Health Effects. Harmful Algae (2004) 5.00

A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid. Environ Health Perspect (2002) 4.14

Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med (2007) 3.72

Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ Health Perspect (2005) 3.38

Occupational exposure to aerosolized brevetoxins during Florida red tide events: effects on a healthy worker population. Environ Health Perspect (2005) 3.27

Brevetoxicosis: red tides and marine mammal mortalities. Nature (2005) 2.87

Brevenal is a natural inhibitor of brevetoxin action in sodium channel receptor binding assays. Cell Mol Neurobiol (2004) 2.77

The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2008) 2.53

Characterization of marine aerosol for assessment of human exposure to brevetoxins. Environ Health Perspect (2005) 2.43

Airway responses to aerosolized brevetoxins in an animal model of asthma. Am J Respir Crit Care Med (2004) 2.40

Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med (2004) 2.34

High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr (2004) 2.31

Environmental exposures to Florida red tides: Effects on emergency room respiratory diagnoses admissions. Harmful Algae (2006) 2.18

Appropriateness of newborn screening for α1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr (2014) 2.10

Fatal hydrops fetalis caused by anti-D in a mother with partial D. Obstet Gynecol (2003) 2.09

Acute phase response in animals: a review. Comp Med (2009) 1.98

Natural and derivative brevetoxins: historical background, multiplicity, and effects. Environ Health Perspect (2005) 1.92

A new polyether ladder compound produced by the dinoflagellate Karenia brevis. J Nat Prod (2005) 1.92

Ciguatera fish poisoning: treatment, prevention and management. Mar Drugs (2008) 1.85

Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80

Overview of aerosolized Florida red tide toxins: exposures and effects. Environ Health Perspect (2005) 1.78

Skill assessment for an operational algal bloom forecast system. J Mar Syst (2009) 1.76

Characterization of Red Tide Aerosol on the Texas Coast. Harmful Algae (2005) 1.75

Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention. Environ Health Perspect (2005) 1.73

Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days. Environ Health Perspect (2005) 1.70

Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med (2005) 1.54

Neurotoxic shellfish poisoning. Mar Drugs (2008) 1.49

The BEACHES Study: health effects and exposures from non-point source microbial contaminants in subtropical recreational marine waters. Int J Epidemiol (2010) 1.49

Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med (2002) 1.48

Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. Chest (2008) 1.47

New fish-killing alga in coastal Delaware produces neurotoxins. Environ Health Perspect (2002) 1.42

Low-volume resuscitation from traumatic hemorrhagic shock with Na+/H+ exchanger inhibitor. Crit Care Med (2009) 1.41

Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma. Chest (2011) 1.40

Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol (2009) 1.39

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39

Traditional and molecular analyses for fecal indicator bacteria in non-point source subtropical recreational marine waters. Water Res (2010) 1.34

Reported respiratory symptom intensity in asthmatics during exposure to aerosolized Florida red tide toxins. J Asthma (2007) 1.34

Investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med (2005) 1.32

Recreational exposure to low concentrations of microcystins during an algal bloom in a small lake. Mar Drugs (2008) 1.29

Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis (2010) 1.28

Recreational exposure to microcystins during algal blooms in two California lakes. Toxicon (2009) 1.28

Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis. Arch Pediatr Adolesc Med (2009) 1.25

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res (2010) 1.23

Brevisamide: an unprecedented monocyclic ether alkaloid from the dinoflagellate Karenia brevis that provides a potential model for ladder-frame initiation. Org Lett (2008) 1.21

Impacts of climate variability and future climate change on harmful algal blooms and human health. Environ Health (2008) 1.21

Effects of storage temperature and time on clinical biochemical parameters from rat serum. J Am Assoc Lab Anim Sci (2009) 1.18

Total synthesis, structure revision, and absolute configuration of (-)-brevenal. J Am Chem Soc (2006) 1.16

Concentration and particle size of airborne toxic algae (brevetoxin) derived from ocean red tide events. Environ Sci Technol (2005) 1.13

Review of Florida Red Tide and Human Health Effects. Harmful Algae (2011) 1.12

Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease. J Pharmacol Exp Ther (2008) 1.11

The costs of respiratory illnesses arising from Florida gulf coast Karenia brevis blooms. Environ Health Perspect (2009) 1.10

Left ventricular function in children with sleep-disordered breathing. Am J Cardiol (2005) 1.10

Influence of lipid-soluble gating modifier toxins on sodium influx in neocortical neurons. J Pharmacol Exp Ther (2008) 1.10

Linking the oceans to public health: current efforts and future directions. Environ Health (2008) 1.09

A review of nitrates in drinking water: maternal exposure and adverse reproductive and developmental outcomes. Environ Health Perspect (2006) 1.08